<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03108664</url>
  </required_header>
  <id_info>
    <org_study_id>SYL1001_IV</org_study_id>
    <secondary_id>2016-003903-79</secondary_id>
    <nct_id>NCT03108664</nct_id>
  </id_info>
  <brief_title>HELIX, a Double-masked Study of SYL1001 in Patients With Moderate to Severe Dry Eye Disease (DED)</brief_title>
  <official_title>HELIX, a Double-masked Study of SYL1001 in Patients With Moderate to Severe Dry Eye</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sylentis, S.A.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sylentis, S.A.</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether SYL1001 ophthalmic solution is safe and
      effective in the treatment of signs and symptoms of Dry Eye Disease.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 18, 2017</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in Visual Analogue Scale (VAS) scores for eye discomfort/pain as a measurement of SYL1001 effect versus vehicle</measure>
    <time_frame>28 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in Corneal Fluorescein Staining (CFS) total scores obtained on the Oxford scale as a measurement of SYL1001 effect versus vehicle</measure>
    <time_frame>28 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in conjunctival hyperaemia scores based on the McMonnies scale as a measurement of SYL1001 effect versus vehicle</measure>
    <time_frame>28 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assessment of Adverse Events Appearance as a measure of SYL1001 tolerability</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Dry Eye Disease</condition>
  <arm_group>
    <arm_group_label>11.25 mg/mL SYL1001 ophthalmic solution</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 drop of 11.25 mg/mL SYL1001 ophthalmic solution in the affected eye(s) q.d</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vehicle ophthalmic solution</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 drop of vehicle ophthalmic solution in the affected eye(s) q.d</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>SYL1001 ophthalmic solution</intervention_name>
    <description>1 drop in the affected eye</description>
    <arm_group_label>11.25 mg/mL SYL1001 ophthalmic solution</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vehicle opthalmic solution</intervention_name>
    <description>1 drop in the affected eye</description>
    <arm_group_label>Vehicle ophthalmic solution</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Both genders

          -  ≥ 18 years old

          -  Give written informed consent to participate in the study after having been informed
             of the study design, objectives and possible derived risks

          -  Common symptoms of persistent, daily, moderate to severe dry eye lasting more than six
             months.

          -  Use of artificial tears

          -  VAS scale for eye discomfort/pain between 30 - 80

          -  CFS ≥ 2 and ≤ 4 on the Oxford scale

          -  TBUT &lt; 10 seconds

          -  Hyperemia score ≥ 1 (McMonnies scale)

          -  Schirmer's test without anesthesia ≥ 2 and &lt; 10 mm/5min in the eye

          -  Corrected visual acuity ≥ 0.7 logMAR

        Exclusion Criteria:

          -  Pregnant or breastfeeding females or those with a positive pregnancy test.

          -  Females of childbearing potential who will not use a medically acceptable
             contraceptive method from selection and during the whole study.

          -  Current relevant disease, including respiratory disease, cardiovascular, endocrine,
             neurological, haematological, renal, neoplasic, hepatopathy, gastrointestinal
             distress, hypertension, or infectious acute processes.

          -  Past history of a chronic o recurring condition that could interfere with study
             according to the investigator's judgement.

          -  Concomitant use of other drugs with analgesic activity by any route of administration
             at the enrolment period.

          -  Changes in any ocular and/or systemic concomitant medication one month prior to the
             study commencement and during the study development.

          -  Changes on the preestablished artificial tears dosage 15 days prior to the study
             commencement and during the study development.

          -  Cyclosporine treatment initiation or changes in cyclosporine dosage or dosing regimen
             during the 6 months prior to enrolment.

          -  Previous history of drug hypersensitivity.

          -  Use of contact lenses

          -  Case history of drug or alcohol abuse or dependence.

          -  Relevant abnormal laboratory results as judged by the investigator

          -  Previous refractive surgery

          -  Participation in a clinical trial within 2 months before the enrolment visit

          -  Relevant ocular pathology judged by the investigator.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Eye Clinic Dr. Krista Turman</name>
      <address>
        <city>Tallinn</city>
        <zip>13419</zip>
        <country>Estonia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>V Ruz</last_name>
      <phone>+34 91 804 76 67</phone>
      <email>info@sylentis.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>East Tallin Central Hospital</name>
      <address>
        <city>Tallin</city>
        <zip>10138</zip>
        <country>Estonia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ruz</last_name>
      <phone>+34 91 804 76 67</phone>
      <email>info@sylentis.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tartu University Hospital</name>
      <address>
        <city>Tartu</city>
        <zip>50406</zip>
        <country>Estonia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>V Ruz</last_name>
      <phone>+34 91 804 76 67</phone>
      <email>info@sylentis.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Augenzentrum Nord-West</name>
      <address>
        <city>Ahaus</city>
        <zip>48683</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>V Ruz</last_name>
      <phone>+34 91 8047667</phone>
      <email>info@sylentis.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitäts-Augenklinik Düsseldorf</name>
      <address>
        <city>Dusseldorf</city>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>V Ruz</last_name>
      <phone>+34 91 8047667</phone>
      <email>info@sylentis.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Freiburg</name>
      <address>
        <city>Freiburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>V Ruz</last_name>
      <phone>+34 91 8047667</phone>
      <email>info@sylentis.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum des Saarlandes</name>
      <address>
        <city>Homburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>V Ruz</last_name>
      <phone>+34 91 8047667</phone>
      <email>info@sylentis.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Uniklinik Köln Zentrum für Augenheilkunde</name>
      <address>
        <city>Köln</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>V Ruz</last_name>
      <phone>+34 91 8047667</phone>
      <email>info@sylentis.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Leipzig AöR Klinik und Poliklinik für Augenheilkunde</name>
      <address>
        <city>Leipzig</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>V Ruz</last_name>
      <phone>+34 91 8047667</phone>
      <email>info@sylentis.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Augenklinik der Ludwig-Maximilian Universität München</name>
      <address>
        <city>Munchen</city>
        <zip>80336</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>V Ruz</last_name>
      <phone>+34 91 8047667</phone>
      <email>info@sylentis.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale San Giuseppe</name>
      <address>
        <city>Milan</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>V Ruz</last_name>
      <phone>+34 91 8047667</phone>
      <email>info@sylentis.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital de Braga</name>
      <address>
        <city>Braga</city>
        <zip>4710-243</zip>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>V Ruz</last_name>
      <phone>+34 91 804 76 67</phone>
      <email>info@sylentis.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Lusiadas Lisboa</name>
      <address>
        <city>Lisboa</city>
        <zip>1500-461</zip>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>V Ruz</last_name>
      <phone>+34 91 8047667</phone>
      <email>info@sylentis.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bellet s.r.o</name>
      <address>
        <city>Martin</city>
        <zip>03601</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>v Ruz</last_name>
      <phone>+34 91 804 76 67</phone>
      <email>info@sylentis.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oftalmologická ambulancia</name>
      <address>
        <city>Trenčín</city>
        <zip>911 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>V Ruz</last_name>
      <phone>+34 91 804 76 67</phone>
      <email>info@sylentis.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fakultná nemocnica Trenčín,</name>
      <address>
        <city>Trenčín</city>
        <zip>911 71</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>V Ruz, PhD</last_name>
      <phone>+34 91 804 76 67</phone>
      <email>info@sylentis.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Optomedic s.r.o</name>
      <address>
        <city>Štúrovo</city>
        <zip>943 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>V Ruz</last_name>
      <phone>+34 91 804 76 67</phone>
      <email>info@sylentis.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>OPHTHAMED, s.r.o.,</name>
      <address>
        <city>Žilina</city>
        <zip>01 001</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>V Ruz</last_name>
      <phone>+34 91 804 76 67</phone>
      <email>info@sylentis.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>VIKOM s.r.o</name>
      <address>
        <city>Žilina</city>
        <zip>010 08</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>V Ruz, PhD</last_name>
      <phone>+34 91 804 76 67</phone>
      <email>info@sylentis.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fakultná nemocnica s poliklinikou Žilina</name>
      <address>
        <city>Žilina</city>
        <zip>012 07</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>V Ruz, PhD</last_name>
      <phone>+34 91 804 76 67</phone>
      <email>info@sylentis.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Instituto Oftalmológico Fernández Vega</name>
      <address>
        <city>Oviedo</city>
        <state>Asturias</state>
        <zip>33012</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>V Ruz</last_name>
      <phone>+34 91 804 76 67</phone>
      <email>info@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Príncipe de Asturias</name>
      <address>
        <city>Alcala de Henares</city>
        <state>Madrid</state>
        <zip>28805</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>V Ruz</last_name>
      <phone>+34 91 804 76 67</phone>
      <email>info@sylentis.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clínica Universidad de Navarra</name>
      <address>
        <city>Pamplona</city>
        <state>Navarra</state>
        <zip>31008</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ruz</last_name>
      <phone>+34 91 804 76 67</phone>
      <email>info@sylentis.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institut Català de la Retina</name>
      <address>
        <city>Barcelona</city>
        <zip>08017</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>V Ruz</last_name>
      <phone>+34 91 804 76 67</phone>
      <email>info@sylentis.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Instituto de Oftalmología del Hospital Clínic de Barcelona Casa de la Maternitat</name>
      <address>
        <city>Barcelona</city>
        <zip>08028</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ruz</last_name>
      <phone>+34 91 804 76 67</phone>
      <email>info@sylentis.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Instituto de Microcirugía Ocular (IMO)</name>
      <address>
        <city>Barcelona</city>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ruz</last_name>
      <phone>+34 91 806 77 57</phone>
      <email>info@sylentis.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico San Carlos</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>V Ruz</last_name>
      <phone>+34 91 804 76 67</phone>
      <email>info@sylentis.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Fundación Jiménez Díaz</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ruz</last_name>
      <phone>+34 91 804 76 67</phone>
      <email>info@sylentis.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Ramón y Cajal</name>
      <address>
        <city>Madrid</city>
        <zip>28043</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ruz</last_name>
      <phone>+34 91 804 76 67</phone>
      <email>info@sylentis.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario la Paz</name>
      <address>
        <city>Madrid</city>
        <zip>28046</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ruz</last_name>
      <phone>+34 91 804 76 67</phone>
      <email>info@sylentis.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen Macarena</name>
      <address>
        <city>Sevilla</city>
        <zip>41009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>V Ruz</last_name>
      <phone>+34 91 804 76 67</phone>
      <email>info@sylentis.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>FISABIO Oftalmología Médica (FOM)</name>
      <address>
        <city>Valencia</city>
        <zip>46017</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>V Ruz</last_name>
      <phone>+34 91 804 76 67</phone>
      <email>info@sylentis.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Provincial Nuestra Señora de Gracia</name>
      <address>
        <city>Zaragoza</city>
        <zip>50004</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ruz</last_name>
      <phone>+34 91 804 76 67</phone>
      <email>info@sylentis.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Estonia</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Portugal</country>
    <country>Slovakia</country>
    <country>Spain</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 30, 2017</study_first_submitted>
  <study_first_submitted_qc>April 5, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 11, 2017</study_first_posted>
  <last_update_submitted>January 24, 2018</last_update_submitted>
  <last_update_submitted_qc>January 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>SYL1001</keyword>
  <keyword>siRNA</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Keratoconjunctivitis Sicca</mesh_term>
    <mesh_term>Dry Eye Syndromes</mesh_term>
    <mesh_term>Eye Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Ophthalmic Solutions</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

